Crystals,
Journal Year:
2022,
Volume and Issue:
12(8), P. 1057 - 1057
Published: July 29, 2022
The
high
frequency
of
nosocomial
bacterial
infections
caused
by
multidrug-resistant
pathogens
contributes
to
significant
morbidity
and
mortality
worldwide.
As
a
result,
finding
effective
antibacterial
agents
is
critical
importance.
Hence,
the
aim
present
study
was
greenly
synthesize
silver
nanoparticles
(AgNPs)
utilizing
Salvia
officinalis
aqueous
leaf
extract.
biogenic
AgNPs
were
characterized
different
physicochemical
techniques
such
as
energy-dispersive
X-ray
spectroscopy
(EDX),
ultraviolet-visible
spectrophotometry
(UV-Vis),
diffraction
analysis
(XRD),
transmission
electron
microscopy
(TEM),
Fourier
transform
infrared
(FT-IR)
analysis.
Additionally,
synergistic
antimicrobial
effectiveness
biosynthesized
with
colistin
antibiotic
against
strains
evaluated
standard
disk
diffusion
assay.
bioformulated
revealed
features,
small
particle
size
17.615
±
1.24
nm
net
zeta
potential
value
−16.2
mV.
elemental
mapping
that
main
element,
recording
relative
mass
percent
83.16%,
followed
carbon
(9.51%),
oxygen
(5.80%),
silicon
(0.87%),
chloride
(0.67%).
disc
assay
showed
potency
tested
pathogens,
highest
efficiency
Escherichia
coli
strain
an
inhibitory
zone
diameter
37.86
0.21
mm
at
concentration
100
µg/disk.
In
addition,
activity
significantly
higher
than
(p
≤
0.05)
multidrug
resistant
namely,
Acinetobacter
baumannii.
antibiotic,
demonstrating
A.
baumannii
(85.57%)
Enterobacter
cloacae
(53.63%),
E.
(35.76%),
Klebsiella
pneumoniae
(35.19%),
Salmonella
typhimurium
(33.06%),
Pseudomonas
aeruginosa
(13.75%).
conclusion,
unique
characteristics
activities
pathogens.
Consequently,
potent
effect
AgNPs–colistin
combination
highlights
this
for
fabrication
highly
coatings
in
intensive
care
units
successful
control
spread
infections.
Antibiotics,
Journal Year:
2022,
Volume and Issue:
11(2), P. 200 - 200
Published: Feb. 4, 2022
Antibiotic
resistance,
and,
in
a
broader
perspective,
antimicrobial
resistance
(AMR),
continues
to
evolve
and
spread
beyond
all
boundaries.
As
result,
infectious
diseases
have
become
more
challenging
or
even
impossible
treat,
leading
an
increase
morbidity
mortality.
Despite
the
failure
of
conventional,
traditional
therapy,
past
two
decades,
no
novel
class
antibiotics
has
been
introduced.
Consequently,
several
alternative
strategies
combat
these
(multi-)
drug-resistant
microorganisms
identified.
The
purpose
this
review
is
gather
consider
that
are
being
applied
proposed
as
potential
alternatives
antibiotics.
These
include
combination
techniques
target
enzymes
proteins
responsible
for
resistant
bacteria,
drug
delivery
systems,
physicochemical
methods,
unconventional
techniques,
including
CRISPR-Cas
system.
may
change
treatment
multi-drug-resistant
pathogens
human
clinical
settings.
Pathogens,
Journal Year:
2023,
Volume and Issue:
12(4), P. 623 - 623
Published: April 20, 2023
Urinary
tract
infections
(UTIs)
are
among
the
most
common
bacterial
worldwide,
occurring
in
both
community
and
healthcare
settings.
Although
clinical
symptoms
of
UTIs
heterogeneous
range
from
uncomplicated
(uUTIs)
to
complicated
(cUTIs),
usually
treated
empirically.
Bacteria
main
causative
agents
these
infections,
although
more
rarely,
other
microorganisms,
such
as
fungi
some
viruses,
have
been
reported
be
responsible
for
UTIs.
Uropathogenic
Escherichia
coli
(UPEC)
is
agent
uUTIs
cUTIs,
followed
by
pathogenic
Klebsiella
pneumoniae,
Proteus
mirabilis,
Enterococcus
faecalis,
Staphylococcus
spp.
In
addition,
incidence
caused
multidrug
resistance
(MDR)
increasing,
resulting
a
significant
increase
spread
antibiotic
economic
burden
infections.
Here,
we
discuss
various
factors
associated
with
UTIs,
including
mechanisms
pathogenicity
related
bacteria
that
cause
emergence
increasing
UTI
pathogens.
Microorganisms,
Journal Year:
2022,
Volume and Issue:
10(6), P. 1239 - 1239
Published: June 16, 2022
Chronic
and
recurrent
bacterial
infections
are
frequently
associated
with
the
formation
of
biofilms
on
biotic
or
abiotic
materials
that
composed
mono-
multi-species
cultures
bacteria/fungi
embedded
in
an
extracellular
matrix
produced
by
microorganisms.
Biofilm
is,
among
others,
regulated
quorum
sensing
(QS)
which
is
interbacterial
communication
system
usually
two-component
systems
(TCSs)
secreted
autoinducer
compounds
activate
signal
transduction
pathways
through
interaction
their
respective
receptors.
Embedded
biofilms,
bacteria
protected
from
environmental
stress
stimuli,
they
often
show
reduced
responses
to
antibiotics,
making
it
difficult
eradicate
infection.
Besides
penetration
antibiotics
intricate
structure
sessile
biofilm-embedded
metabolic
activity
them
intrinsically
less
sensitive
antibiotics.
Moreover,
express
elevated
levels
efflux
pumps
extrude
thereby
reducing
intracellular
levels.
Some
involved
secretion
QS
biofilm-related
materials,
besides
being
important
for
removing
toxic
substances
bacteria.
pump
inhibitors
(EPIs)
have
been
shown
both
prevent
biofilm
sensitize
suggesting
a
relationship
between
these
processes.
Additionally,
quenchers
may
affect
antibiotic
susceptibility.
Thus,
targeting
elements
regulate
might
be
promising
approach
combat
antibiotic-resistant
infections.
Antibiotics,
Journal Year:
2023,
Volume and Issue:
12(3), P. 628 - 628
Published: March 22, 2023
The
necessity
for
the
discovery
of
innovative
antimicrobials
to
treat
life-threatening
diseases
has
increased
as
multidrug-resistant
bacteria
spread.
Due
antibiotics’
availability
over
counter
in
many
nations,
antibiotic
resistance
is
linked
overuse,
abuse,
and
misuse
these
drugs.
World
Health
Organization
(WHO)
recognized
12
families
that
present
greatest
harm
human
health,
where
options
therapy
are
extremely
limited.
Therefore,
this
paper
reviews
possible
new
ways
development
novel
classes
antibiotics
which
there
no
pre-existing
bacterial
pathogens.
By
utilizing
research
technology
such
nanotechnology
computational
methods
(such
silico
Fragment-based
drug
design
(FBDD)),
been
an
improvement
antimicrobial
actions
selectivity
with
target
sites.
Moreover,
alternatives,
peptides,
essential
oils,
anti-Quorum
sensing
agents,
darobactins,
vitamin
B6,
bacteriophages,
odilorhabdins,
18β-glycyrrhetinic
acid,
cannabinoids.
Additionally,
repurposing
ticagrelor,
mitomycin
C,
auranofin,
pentamidine,
zidovudine)
synthesis
antibacterial
agents
(including
lactones,
piperidinol,
sugar-based
bactericides,
isoxazole,
carbazole,
pyrimidine,
pyrazole
derivatives)
represent
approaches
treating
infectious
diseases.
Nonetheless,
prodrugs
(e.g.,
siderophores)
have
recently
shown
be
excellent
platform
a
generation
better
efficacy
against
bacteria.
Ultimately,
combat
resistant
stop
spread
illnesses,
regulations
public
education
regarding
use
hospitals
agricultural
sector
should
combined
technological
advancements.
Infection and Drug Resistance,
Journal Year:
2023,
Volume and Issue:
Volume 16, P. 7515 - 7545
Published: Dec. 1, 2023
Abstract:
Antimicrobial
resistance,
referring
to
microorganisms'
capability
subsist
and
proliferate
even
when
there
are
antimicrobials
is
a
foremost
threat
public
health
globally.
The
appearance
of
antimicrobial
resistance
can
be
ascribed
anthropological,
animal,
environmental
factors.
Human-related
causes
include
overuse
misuse
in
medicine,
antibiotic-containing
cosmetics
biocides
utilization,
inadequate
sanitation
hygiene
settings.
Prophylactic
therapeutic
overuse,
using
as
feed
additives,
microbes
resistant
antibiotics
genes
animal
excreta,
residue
found
animal-origin
food
excreta
animals
related
contributive
factors
for
the
antibiotic
emergence
spread.
Environmental
including
naturally
existing
genes,
improper
disposal
unused
antimicrobials,
contamination
from
waste
settings,
farms,
pharmaceutical
industries,
use
agricultural
chemicals
facilitatet
its
Wildlife
has
plausible
role
Adopting
one-health
approach
involving
properly
humans,
improving
spaces
implementing
coordinated
governmental
regulations
crucial
combating
resistance.
Collaborative
cooperative
involvement
stakeholders
public,
veterinary
ecological
sectors
circumvent
problem
effectively.
Keywords:
one
health,
gene,
environment,
wildlife
The Innovation,
Journal Year:
2023,
Volume and Issue:
4(6), P. 100503 - 100503
Published: Aug. 29, 2023
•Insights
into
the
intricate
facets
of
immune
microenvironment
hold
key
to
pioneering
clinical
strategies
in
combatting
bacterial
infections.•The
design
principles
for
antimicrobial
biomaterials
vary
depending
on
at
different
stages
infection.•Immunomodulatory
display
robust
efficacy
and
vaccine
attributes
animals
trials,
promising
intractable
infections.
Bacterial
infectious
diseases
are
one
leading
causes
death
worldwide.
Even
with
use
multiple
antibiotic
treatment
strategies,
4.95
million
people
died
from
drug-resistant
infections
2019.
By
2050,
number
deaths
will
reach
10
annually.
The
increasing
mortality
may
be
partly
due
heterogeneity
infection
microenvironment,
such
as
bacteria,
biofilms,
persister
cells,
intracellular
small
colony
variants.
In
addition,
complexity
makes
direct
activity
unsatisfactory
long-term
chronic
attributed
failing
modulate
active
action
cells.
Therefore,
there
is
an
urgent
need
effective
alternatives
treat
Accordingly,
development
immunomodulatory
has
recently
received
considerable
interest;
however,
a
comprehensive
review
their
research
progress
lacking.
this
review,
we
focus
mainly
future
perspectives
used
infection.
First,
describe
characteristics
acute
phases
Then,
highlight
corresponding
advantages
disadvantages.
Moreover,
discuss
biomaterial-mediated
vaccines'
potential
applications
challenges
activating
innate
adaptive
memory.
This
serve
reference
studies
develop
next-generation
accelerate
translation
practice.
Pharmacology & Pharmacy,
Journal Year:
2023,
Volume and Issue:
14(08), P. 271 - 328
Published: Jan. 1, 2023
Background:
Antimicrobial
resistance
(AMR)
is
a
global
health
challenge
that
has
escalated
due
to
the
inappropriate
use
of
antimicrobials
in
humans,
animals,
and
environment.
Developing
implementing
strategies
reduce
combat
AMR
critical.
Purpose:
This
study
aimed
highlight
some
can
be
implemented
address
using
One
Health
approach.
Methods:
employed
narrative
review
design
included
studies
published
from
January
2002
July
2023.
The
searched
for
literature
on
antimicrobial
stewardship
(AMS)
PubMed
Google
Scholar
2020
PRISMA
guidelines.
Results:
reveals
remains
significant
public
problem.
Its
severity
been
markedly
exacerbated
by
broader
ecological
Several
have
developed
AMR,
including
Global
Action
Plan
(GAP),
National
Plans
(NAPs),
AMS
programs,
implementation
AWaRe
classification
antimicrobials.
These
also
involve
strengthening
surveillance
consumption
resistance,
encouraging
development
new
antimicrobials,
enhancing
regulations
around
prescribing,
dispensing,
usage.
Additional
measures
include
promoting
partnerships,
combating
substandard
falsified
advocating
vaccinations,
sanitation,
hygiene
biosecurity,
as
well
exploring
alternatives
However,
these
faces
various
challenges.
challenges
low
awareness
knowledge
shortage
human
resources
capacity
building
AMS,
adequate
funding
initiatives,
limited
laboratory
capacities
surveillance,
behavioural
change
issues,
ineffective
leadership
multidisciplinary
teams.
Conclusion:
In
conclusion,
this
established
prevalent
among
Successfully
addressing
calls
collaborative,
multifaceted
Despite
this,
gaps
remain
effectively
currently
recommended
AMR.
As
result,
it
essential
reinforce
are
deployed
counter
across
human,
animal,
environmental
sectors.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(5), P. 2655 - 2655
Published: Feb. 24, 2024
One
of
the
key
mechanisms
enabling
bacterial
cells
to
create
biofilms
and
regulate
crucial
life
functions
in
a
global
highly
synchronized
way
is
communication
system
called
quorum
sensing
(QS).
QS
cell-to-cell
process
that
depends
on
population
density
mediated
by
small
signalling
molecules
autoinducers
(AIs).
In
bacteria,
controls
biofilm
formation
through
regulation
gene
expression
involved
extracellular
polymeric
matrix
(EPS)
synthesis,
virulence
factor
production,
stress
tolerance
metabolic
adaptation.
Forming
one
antimicrobial
resistance
(AMR).
A
common
feature
human
pathogens
ability
form
biofilm,
which
poses
serious
medical
issue
due
their
high
susceptibility
traditional
antibiotics.
Because
associated
with
formation,
there
belief
inhibition
activity
quenching
(QQ)
may
provide
alternative
therapeutic
methods
for
treating
microbial
infections.
This
review
summarises
recent
progress
research,
focusing
biofilms,
especially
those
formed
pathogenic
become
resistant
antibiotic
treatment.
Subsequently,
potential
approach
highlighting
innovative
non-antibiotic
strategies
control
AMR
bacteria
has
been
discussed.